SCHEMBL1633877

SCHEMBL1633877

NS(=O)(=O)c1ccc(Nc2ncc3ccc(-c4cccnc4)c(-c4cccnc4)c3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 8/20 0.54
MEN1 O00255 1/20 0.53
NPC1 O15118 1/20 0.53
KMT2A Q03164 1/20 0.53
NCOA3 Q9Y6Q9 1/20 0.53
DKK1 O94907 1/20 0.49
GSK3B P49841 1/20 0.49
CA2 P00918 5/20 0.49
CA1 P00915 4/20 0.49
CA9 Q16790 4/20 0.49
CA12 O43570 3/20 0.49
JAK2 O60674 1/20 0.45
DYRK1A Q13627 1/20 0.45
CCNT1 O60563 2/20 0.45
CDK1 P06493 2/20 0.45
CCNB1 P14635 2/20 0.45
CDK9 P50750 2/20 0.45
CA4 P22748 1/20 0.45
MAPK8 P45983 1/20 0.45
MAPK10 P53779 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1632468 0.87 MEN1 (0.55) IKBKBMEN1NPC1KMT2ANCOA3
SCHEMBL1632691 0.85 IKBKB (0.50) IKBKBDKK1GSK3BCA2CA1
SCHEMBL1632094 0.84 IKBKB (0.47) IKBKBDKK1GSK3BCA2CA1
SCHEMBL7470673 0.80 IKBKB (0.81) IKBKBMEN1NPC1KMT2ANCOA3
SCHEMBL1633311 0.79 CA2 (0.56) IKBKBMEN1NPC1KMT2ANCOA3
SCHEMBL1633013 0.79 CDK2 (0.61) IKBKBCA2CA1CA9CCNT1
SCHEMBL1632243 0.79 IKBKB (0.47) IKBKBMEN1NPC1KMT2ANCOA3
SCHEMBL1633294 0.78 CDK2 (0.65) IKBKBCA2CA1CA9CCNT1
SCHEMBL13498353 0.78 TTK (0.38) CA2CA1CA9CA12DYRK1A
SCHEMBL1633248 0.76 IKBKB (0.53) IKBKBMEN1NPC1KMT2ANCOA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed